Steele Clarke Smith, Iii Email & Phone Number

Idrasil™ is a 12.5mg, 25mg, 100mg Tablet; The first titratable form that solves the problem associated with prescribing Cannabis. Rx Idrasil™ is Major insurance Reimbursable and has a standardized and consistent formula that allows physicians and caregivers the ability to provide patients with a measurable dosage. The ONLY, all natural” Medical Cannabis Rx recognized and paid for by most health insurance providers in California. With Idrasil™, patients are alert, lucid, happy and enjoy more Quality of Life (QoL) with their families. We at C3® are Committed to the Highest Standards of Scientific Technology and Research in Cannabinoid Innovation.Steele C. Smith, III is a native Californian and entrepreneur of natural & complimentary medical therapies, as well as national advocate for safe patient access to holistic medicine. He is the founding Chairman of C3® International, Inc., manufacturer of the unique I.P. Holding for Idrasil™. The nutraceutical, Idrasil™ is the world's first & only naturally derived, non-synthetic, pharmaceutical grade cannabis, in the form of a discreet, titratable, Rx Tablet. As an expert in cannabinoid therapeutics, Steele along with his wife, Theresa Ann Smith, are pioneers of cannabis collectives under California's Compassionate Use Act of 1996, founding California Compassionate Caregivers (C3) Cannabis Collective, in 2006.Steele's ongoing compassion for patients suffering from the effects of disease and their related treatments inspired him to start a collective after time spent volunteering with AIDS Project Los Angeles, during the height of the AIDS crisis, in the mid-nineties. Today, he works tirelessly, educating the still naive medical community to the incredible reality of the medicinal benefits of cannabinoid therapeutics, nationwide.

Listed skills include Social Networking, Public Speaking, Marketing Strategy, Entrepreneurship, and 14 others.

• 

  University Of Southern California

  English